This is noteworthy because, currently, the AR and PI3K signalling pathways are used as therapeutic targets in aggressive PCa, as androgen-deprivation therapy (ADT) is one of the most effective therapeutic modalities [61, 62]. Here, AR is linked to posterior cortical atrophy.